European Journal of Hospital Pharmacy

Article	Citations
Medication stability: from pharmacies to patients’ homes—is consistent storage achievable?	63
Broad perspective on the relationship between soticlestat and QT interval in patients with epilepsy	17
Natural language processing assisted detection of inappropriate proton pump inhibitor use in adult hospitalised patients	14
Is standard induction with mirikizumab sufficient in refractory ulcerative colitis in real-world practice?	13
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations	13
Development of a 50% (w/v) aluminium chloride hexahydrate solution as haemostatic agent	13
Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings	13
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years	13
Antithrombotic stewardship: whether to stop anticoagulation after atrial fibrillation ablation	12
Impact of CYP2C19 genotyping on clopidogrel therapy adjustments in patients with stroke or TIA	12
Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease	10
Advanced therapy medicinal products	10
Correspondence on “Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements	9
EJHP’s impact factor moves on up	9
Hypoglycaemic coma induced by a falsified semaglutide product: a case report	9
Assessing health outcomes: a systematic review of electronic patient-reported outcomes in oncology	9
Empowering European hospital pharmacists in the face of heart failure	9
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Ze	9
The threatened medicines information pharmacist!	9
Medication safety strategies in European adult, paediatric, and neonatal intensive care units: a cross-sectional survey	8
Expanded expiry dates: a regulatory opportunity for Europe	8
Rare complication of doxorubicin-induced complete heart block in a patient with Hodgkin’s lymphoma: a case report	8
Drug–drug interactions in adjuvant and neoadjuvant breast cancer therapy	7
Business continuity plans for hospital pharmacies: a Delphi consensus	7
Extended physicochemical stability of ready-to-administer fosnetupitant/palonosetron infusion solutions and admixtures with dexamethasone injection	7

EAHP’s COVID-19 Report showcases the contributions of hospital pharmacists and shares recommendations	6
Pharmaceutical validation of peripherally inserted central catheters: four years of implementation	6
A retrospective hospital benefit and cost analysis of the management of human tissues for orthopaedic allografts	6
Hospital pharmacists in cardio-oncology: bridging a critical gap in multidisciplinary cancer care	6
Cost-effectiveness of preoperative pharmaceutical care consultations: a 5-year analysis	6
The end of an era!	6
Optimisation of the quality of care for patients with severe asthma: ASfarMA project	6
Hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction: a case report	6
Response to: Correspondence on ‘Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake	6
EAHP’s special interest group on hospital pharmacist’s preparedness for in-vivo GTMP publishes report	6
Development and validation of a feasible questionnaire to assess pharmacists’ attitudes to documenting and classifying pharmaceutical interventions in hospital settings	6
Beta-lactam allergy in patients: an antibiotic stewardship challenge	5
177Lu-Dotatate administration using an infusion pump or a peristaltic pump: comparison of two methods	5
Medicinal mushrooms and chemotherapy: therapeutic synergy or hidden risk?	5
Inhaled aztreonam lysine in the management ofPseudomonas aeruginosain patients with cystic fibrosis: real-life effectiveness	5
Risk factors for unintentional medication discrepancies identified through pharmacy staff-led medication reconciliation to prioritise patients in the emergency department: a rapid review	5
EMA guidance for industry to prevent and mitigate medicine shortages	5
Challenges and opportunities for hospital pharmacists in the management of gene and cell therapies	5
Long-term stability of esketamine in polypropylene syringes at 5 ± 3°C	5
Antifungal prophylaxis against invasive Candida and Aspergillus infection in adult heart transplant recipi	5
The importance of authorship integrity in scientific publications within healthcare and hospital pharmacy	4
Ceftriaxone-induced thrombocytopenia during tuberculosis treatment: a case report	4
Switching anti-CGRP monoclonal antibodies in chronic migraine: real-world observations of erenumab, fremanezumab and galcanezumab	4
Colchicine–enzalutamide interaction: clinical implications and multi-disciplinary management	4
Response to correspondence on ‘Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approac	4
Patient reported medication-related problems, adherence and waste of oral anticancer medication over time	4
Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements	4
Pharmaceutical consultation on patients receiving oral antineoplastic agents: a systematic review	4
Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach	4
Digitalisation of the drug prescribing process in Swiss hospitals – results of a survey	4
Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence	4
Drug-induced acute generalised exanthematous pustulosis: insights from FAERS data on a rare but severe cutaneous adverse reaction	4
Evaluation of statin-induced muscle and liver adverse drug reactions in the Chinese population: a retrospective analysis of clinical trial data from 1992 to 2023	4
A collaborative telepharmacy model for dispensing and informed delivery from hospital to community pharmacies	4
Clinical trials	4
Capecitabine: guaranteed access in adjuvant treatment of breast cancer	3
Container closure integrity testing and process validation of closed system transfer devices for aseptic reconstitution of drug vials connected to fluid bags	3
Medication-related problems in critical care survivors: a systematic review	3
Predictive performance of glomerular filtration rate equations based on cystatin C, creatinine and their combination in critically ill patients	3
The future of pharmacy is already here: can we afford not to invest? Reflections from the seventh EAHP Synergy Certification Course 2025 in Bratislava	3
Budd-Chiari syndrome after BNT162b2 mRNA vaccination: two case reports	3
Effectiveness and safety of off-label dupilumab use for the treatment of pemphigoid gestationis: a new case report	3
Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients	3
Cannabis hyperemesis syndrome: an emerging clinical and public health challenge	3
Update on the hospital pharmacist profile: from clinical practice to management	3
Hypomagnesaemia with niraparib: the need for comprehensive adverse effect reporting in drug labelling	3
Using machine learning or deep learning models in a hospital setting to detect inappropriate prescriptions: a systematic review	3
In-hospital expenditure for medical devices in relation to funds from diagnosis-related groups and ambulatory activity: temporal trend from 2019 to 2022	3
Clinical pharmacy as a guarantee of safety in times of crisis: evolution and relevance of the continued presence of clinical pharmacists in frontline medical units during the first wave of COVID-19	3
Infectious diseases and antimicrobial resistance	3

Implementation of pharmaceutical infusion management to reduce incompatibilities and fluid overload: a retrospective observational study in a paediatric intensive care unit	3
Medication adherence interventions: where are we and where do we go?	3
Drug repositioning in Alzheimer’s disease: a vascular perspective targeting the NO-cGMP pathway	3
Pharmacological resilience in the context of geopolitical tensions: a European perspective	3
Fully validated HPLC-UV detection method associated with colour variation control for evaluation of the stability of 5-fluorouracil chemotherapy polyolefin infusion bags at dose banding	3
Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing	3
How to manage the overwhelming amount of database-detected interactions? A focus group meeting study on the management of database-detected risks of drug interactions	3
Sodium thiosulfate in calciphylaxis: the importance of accurate dose-unit reporting	3
Curcumin supplements in patients with breast cancer treated with CDK4/6 inhibitors: a silent pharmacokinetic risk	3
Organisational impact of in vivo gene therapies at two French injection centres	3
Switching of anti-migraine antibodies: effectiveness or regression to the mean?	3
Systematic review of room temperature stability of key beta-lactam antibiotics for extended infusions in inpatient settings	3
Women and adverse drug reactions: 56 years of analysis of real-world data collected in the FDA adverse event reporting system (FAERS) database	3
Influence of baseline characteristics and stratification level of patients living with HIV on pharmaceutical interventions developed according to the Capacity-Motivation-Opportunity methodology	3
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series	3
Stability assessment and content determination test of oral liquid forms of beclomethasone dipropionate prepared in hospital pharmacy	2
Formulation and stability study of an oral paediatric phenobarbital 1% solution containing hydroxypropyl-β-cyclodextrins	2
EAHP sets out to future-proof the hospital pharmacy workforce	2
Stability of oxycodone solutions containing S -ketamine or dexmedetomidine	2
Patient safety culture and medication safety in European intensive care units: a focus group study	2
Response to: Correspondence on “Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approa	2
Practical guide for the selection of digital solutions oriented to PROMs and PREMs in the hospital pharmacy	2
Identical but lethal: managing the LASA risk of plastic potassium chloride ampoules through organisational constraints	2
Older people, medication usage and long-term care pharmacists: a retrospective cohort study	2
Fixed or weight-adjusted dose in immunotherapy?	2
Results of EAHP’s 2023 shortages survey	2
Unit dose drug dispensing systems in hospitals: a systematic review of medication error reduction and cost-effectiveness	2
Haemodynamic effects of intravenous acetaminophen in critically ill paediatric patients: a retrospective chart review	2
Physical compatibility of ceftazidime-avibactam with selected intravenous antimicrobials in simulated Y-site administration	2
Introduction to an online only issue	2
Appropriateness of antithrombotics in geriatric inpatients with atrial fibrillation: a retrospective, cross-sectional study	2
Clinical and economic benefits of expanded access programs: should we strengthen these pharmacist-led initiatives?	2
Reuse of fixed-dose monoclonal antibodies in oncology: retrospective and pharmacoeconomic analysis in a chemotherapy reconstitution unit	2
Do junior doctors make more prescribing errors than experienced doctors when prescribing electronically using a computerised physician order entry system combined with a clinical decision support syst	2
Comparison of adverse drug reactions of statins in China from 1989 to 2019	2
Harm to a child caused by the off-label use of prochlorperazine maleate tablets due to the discontinuation of licensed prochlorperazine mesilate liquid in the UK	2
Assessment of particle contamination in vancomycin syringe pumps following fluid withdrawal using three diverse aseptic reconstitution techniques	2
Performance and risks of ChatGPT used in drug information: comment	2
The Granada Statements: an impact boost to clinical and social pharmacy publications, part 1	2
Pharmaceutical care in the screening process of phase I oncohaematological clinical trials	2
Extravasation of brentuximab vedotin, an antibody-drug conjugate, in a patient with anaplastic large cell lymphoma	2
When gravimetry is debated by sponsors of clinical studies	2
Thirty congresses: What a journey!	2
Drug intoxication: a silent obstacle to organ donation	2
Association of acamprosate versus gabapentinoids with liver disease progression and alcohol-related admissions in patients with alcohol use disorder	2
Evaluation of resources for effective decision-making about drug manipulation	2
Using local clinical rules in a pharmacy service to detect risk prescriptions in older adult hospital inpatients: a proof-of-concept study	2
Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations	2
Ultra-low temperature storage of advanced therapy medicinal products in hospital pharmacies: findings from a national survey of French hospital pharmacists	2
Realising potential and addressing risk: a UK survey of adult hepatology pharmacy services	2
Pharmacist-led patient education improves medication self-management and adherence in chronic hepatitis D virus patients: insights from the EXPLAIN project	2
Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy	2
The secret life of the surgical pharmacy in high risk periods	2
Deep learning classification of drug-related problems from pharmaceutical interventions issued by hospital clinical pharmacists during medication prescription review: a large-scale descriptive retrosp	2
Integrating automated dispensing cabinets into the medication dispensing process: feedback from the practice in European hospitals	2
Beyond conventional dosing: tailoring antimicrobial regimens for cachexia	2
Safeguarding antimicrobial medicines reserved for treating humans	2
Physicochemical stability of a polysorbate-80-containing solvent compounded in the hospital pharmacy and used to reconstitute a biologic for nebulisation	2
Performance evaluation of the HPLC diode array and evaporative light scattering detection for the implementation of dose-banded gemcitabine infusion bags	2
Digital health	2
Anticholinergic burden and revisit risk in frail patients with pharmacological sleepiness	2
Monitoring of occupational exposure to hazardous medicinal products in robotic compounding	2
Study of therapeutic patient education practices in French renal transplantation centres	2
Hospital pharmacy workforce	2
Public information on shortages in the EU/EEA: improvements made between 2018 and 2020	2
Retrospective service evaluation of clinical pharmacist involvement in a critical care COVID-19 rehabilitation clinic	2
Looking back and looking forward	2
Capillary electrophoresis in parenteral nutrition control – validation of two analytical methods: Amino acids/glucose/glucose-1-phosphate and K/Na/Ca/Mg	2
Over 40% of cancer patients use complementary and alternative medications while receiving anticancer treatment	2
Physical compatibility of ceftriaxone and cefepime in 0.45% sodium chloride, Ringer’s lactate solution, and Plasma-Lyte A	2
Liquid antimicrobials: a national analysis of critical shortages	2
Home antibiotic therapy in elastomeric infusion pumps – past, present and future	2
Retrospective study of plasma anti-Xa levels in renally impaired patients receiving reduced or non-reduced therapeutic doses of dalteparin	2
To maximise impact, hospital pharmacists need to increase visibility	2
Systematic review of independent pharmacist prescribing for the treatment of cardiometabolic factors in chronic non-communicable diseases	2
On-label paediatric drug product information in Switzerland – the neglected child	2
Implementation of pharmacists’ monitoring for intravenous drug compatibility	2
Ceftaroline combination therapy for methicillin resistant coagulase negative Staphylococcus bacteraemia and endocarditis	2
Correspondence on “Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach” by Protze	2
Stability of clozapine tablets repackaged in dose administration aids using repackaging machines	2

Medication adherence in chronic myeloid leukemia: a hospital pharmacy-level analysis	2
Optimising electronic health records for highly specialised hospital areas: a call for collaborative hospital pharmacist involvement	1
Assessment of antibiotic self-medication practice among public in the northwestern region of Pakistan	1
Retrospective study of patient characteristics and treatment for mucormycosis in post COVID-19 population in a tertiary care hospital	1
Physicochemical and biological stability of diluted vedolizumab in intravenous infusion bags	1
Ciclosporin-related posterior reversible encephalopathy syndrome in a paediatric haematopoietic stem cell transplant recipient	1
Choose carefully where to publish your research	1
Contribution of hospital pharmacists to sustainable healthcare: a systematic review	1
Addressing the at-home care needs of patients with multidrug-resistant bacteria: what should we do?	1
Predicting unplanned hospital revisits among community-dwelling older adults: a dynamic cohort study	1
Evolution of hospital clinical pharmacy services in Finland in the period 2017–2022: the third nationwide follow-up survey	1
Compatibility and physicochemical stability of ceftriaxone for injection admixed with pantoprazole sodium and ondansetron hydrochloride in different infusion solutions	1
Hospital pharmacists’ first impressions on the revision of the General Pharmaceutical Legislation	1
When simple syrup is not so simple: pH-dependent instability of an extemporaneous oxybutynin oral solution	1
Correspondence on ‘Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach’ by Protze	1
The optimisation of extemporaneous compounding of low-dose nifedipine capsules	1
Gender bias in biomedical research	1
An essential component of antimicrobial stewardship during the COVID-19 pandemic in the intensive care unit: de-escalation	1
Qualification and impact of a video-assisted control system in a chemotherapy compounding unit	1
Ifosfamide-induced encephalopathy and concomitant use of netupitant/palonosetron in a patient with soft tissue sarcoma: a case report	1
Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study	1
Towards precision antibiotic therapy: predictors and outcomes of meropenem target attainment	1
Digitising controlled substance accountability: implementation and use of a dashboard-based monitoring system in an university hospital	1
Taking care of caregivers: enhancing proper medication management for palliative care children with polypharmacy	1
Risk of exposure of patients’ family members to lenalidomide at home	1
Beyond the 5S methodology applied to healthcare management	1
Enhancing depression management in older cancer patients: the pharmacist’s role	1
Potential risk of non-arteritic anterior ischaemic optic neuropathy in semaglutide users: pharmacovigilance insights	1
Physicochemical stability of bevacizumab biosimilar CT-P16 (Vegzelma) concentrate for solution stored in original vials after first opening	1
Correspondence on ‘COVID-19 vaccine triggered autoimmune hepatitis: case report’ by Mathewet al	1
Management of heparin-induced thrombocytopenia during extracorporeal membrane oxygenation support: a case of neutropenia caused by argatroban anticoagulation	1
Modulation of cytochrome P450 and P-glycoprotein by Ashwagandha ( Withania somnifera ): implications for CDK4/6 inhibitor therapy	1
Therapeutic options carried out after hypersensitivity reactions to chemotherapy: the value of skin tests	1
A pilot study investigating the clinical and financial impact of a pharmacist discharge service in a hospital setting	1
Artificial intelligence and innovation in hospital pharmacy: embracing opportunities	1
Medication reconciliation at patient admission in psychiatric setting: prioritisation tool to reduce medication errors (O-PsyConcil)	1
Universal high-dose meropenem for antimicrobial-resistant Gram-negative infections: evidence or overreach?	1
Costs, challenges and opportunities of decentralised chimeric antigen receptor T-cell production: a literature review and clinical experts’ interviews	1
Drug-related problems at the heart of cardiac surgery	1
Physicochemical stability of ready-to-administer mitomycin C solutions for intravesical instillation	1
EAHP general assembly updates position paper on clinical trials	1
Adverse drug reactions in paediatric age: analysis of spontaneous reports and reasons for under-reporting in a Local Health Unit in Veneto region	1
Nine years’ experience of an educational programme for patients treated with oral anticoagulants in a cardiology department	1
Use of the ‘Making Medicines Work for You’ screener to identify medication adherence barriers in heart failure patients	1
Mobile pharmacies of the Ukrainian chain ‘Apteka 9-1-1’: access to medicines during the war in Ukraine	1
Visual compatibility and particle counter evaluations of syringes of intramuscular psychotropic coadministered solutions	1
Drug shortages: A critical challenge in the era of automated intravenous compounding	1
Is one enough?	1
Evaluation of professional practices in hospital radiopharmacy using a process-based clinical audit: a quality improvement study	1
Spice-drug interactions: a case report on the use of turmeric, curry and ginger in a renal transplant patient on tacrolimus	1
Posaconazole therapeutic drug monitoring in haematologic malignancies: a persistent practice gap	1
A new function in the Stabilis database: physical compatibility and incompatibility of injectable drugs to secure Y-site administration	1
Maintaining appropriate stocks in an operating room pharmaceutical unit: risk mapping of the supply chain.	1
Stability of dexmedetomidine, ketamine and lidocaine combined injectable solution for analgesia	1
Polymyxin B-related neurotoxicity: a brief case report	1
Game-based training to promote handwashing, handrub and gloving for hospital pharmacy operators	1
Reimagining the ADR Alert Card: a novel approach to recurrence prevention in low-cost settings for adverse drug reactions	1
Physicochemical stability of the nefopam in elastomeric device at 0.2 and 3.33 mg/mL	1
Physical compatibility of insulin aspart, lidocaine, alprostadil and vancomycin with individualised two-in-one parenteral nutrition used in the neonatal intensive care unit	1
Prescribe less, ask more: the patient-centred pharmacology we need	1
Successful desensitisation to paclitaxel with omalizumab	1
Physicochemical stability of pevonedistat at 50, 100 and 200 µg/mL diluted in 0.9% sodium chloride and at 10 mg/mL in partially used vials	1
Maintaining the stability of furosemide tablets during enteral feeding tube delivery using PVC and non-PVC tubes, in accordance with hospital protocols	1
Paracetamol loading dose administration in children: a retrospective study	1
Impact of the use of a drug–drug interaction checker on pharmacist interventions involving well-known strong interactors	1
Education and research practices in Irish hospital pharmacies: a national service evaluation by the Hospital Pharmacists Association of Ireland Specialist Interest Group on Education and Research	1
EAHP-EANM joint statement	1
Risk factors for early onset acute kidney injury after allogeneic haematopoietic stem cell transplantation and the role of drug–drug interactions	1
Manipulating prednisolone tablets for paediatric adjustments – dose accuracy and precision	1
Selection of initiatives to improve the management of patients with hereditary angioedema by the hospital pharmacy using the nominal group technique	1
Correlation between antibiotic use and resistance of gram-negative bacteria at a university hospital in Japan from 2013 to 2021: a study using the Japan Surveillance for Infection Prevention and Healt	1
Feasibility study of the digital tool Max for the patient-provided medication list in the medication reconciliation process prior to hospitalisation: patient willingness and usability, time saved and	1
Comparison of sodium zirconium cyclosilicate and sodium polystyrene sulfonate in the treatment of acute hyperkalaemia	1
Clopidogrel-induced thrombotic microangiopathy: a case report	1
Impact of patient-centred care and population health management on diabetes and hypertension outcomes	1
Use of chronic medications and risk of death due to COVID-19 in hospitalised patients	1
Is peer review running out of steam?	1
Scarce plasma, rising demand: why pharmacist-led immunoglobulin stewardship matters	1
Comparison of outcomes for fixed and weight-based four-factor prothrombin complex concentrate dosing regimens	1
Evaluation of drug cost savings related to clinical trials from the perspective of a university hospital	1